vTv Therapeutics Inc. (VTVT)
19.66
1.26 (6.85%)
At close: Feb 28, 2025, 3:53 PM
19.66
0.00%
After-hours: Feb 28, 2025, 03:53 PM EST
vTv Therapeutics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | n/a | 2.02M | 4M | 6.41M | 2.76M | 12.43M | 291K | 634K | 519K | 1.55M | 976K |
| Cost of Revenue | 13.6M | 92K | 89K | 11.02M | 15.12M | 23.04M | 39.64M | 45.75M | 29.58M | 18.73M | 25.43M |
| Gross Profit | -13.6M | 1.93M | 3.92M | -4.6M | -12.36M | -10.6M | -39.35M | -45.11M | -29.07M | -17.18M | -24.46M |
| Operating Income | -25.5M | -22.54M | -21.66M | -11.85M | -20.89M | -19.82M | -50.68M | -55.02M | -38.14M | -28.9M | -35.83M |
| Interest Income | 472K | 352K | 1K | 12K | 53K | 61K | 117K | 87K | n/a | n/a | n/a |
| Pretax Income | -25.97M | -24.87M | -17.62M | -12.8M | -21.84M | -23.64M | -53.85M | -55.35M | -41.11M | -36.1M | -48.2M |
| Net Income | -20.25M | -25.07M | -17.73M | -8.83M | -21.94M | -7.91M | -16.14M | -16.35M | -27.5M | -36.1M | -48.2M |
| Selling & General & Admin | 11.91M | 12.2M | 12.34M | 7.25M | 8.54M | 9.22M | 11.33M | 9.91M | 9.08M | 11.72M | 11.38M |
| Research & Development | 13.51M | 12.36M | 13.32M | 11.02M | 15.12M | 23.04M | 39.64M | 45.75M | 29.58M | 18.73M | 25.43M |
| Other Expenses | -13.51M | -2.67M | 4.06M | -270K | 828K | -592K | -190K | -22K | -2.96M | -1.13M | -534K |
| Operating Expenses | 11.91M | 24.56M | 25.67M | 18.27M | 23.66M | 32.26M | 50.97M | 55.65M | 38.66M | 30.45M | 36.81M |
| Interest Expense | 13K | 15K | 12K | 692K | 1.83M | 3.29M | 3.09M | 398K | 1.74M | 6.01M | 11.82M |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 25.5M | 24.56M | 25.67M | 18.27M | 23.66M | 32.26M | 50.97M | 55.65M | 38.66M | 30.45M | 36.81M |
| Income Tax | n/a | 200K | 115K | -3.98M | 100K | 200K | 800K | -39M | -14.11M | 4.88M | 11.29M |
| Shares Outstanding (Basic) | 2.08M | 1.92M | 1.57M | 1.18M | 757.3K | 311.23K | 242.33K | 238.64K | 206.91K | 207.63K | 205.49K |
| Shares Outstanding (Diluted) | 2.08M | 1.92M | 1.57M | 1.18M | 757.3K | 311.23K | 242.33K | 238.64K | 206.91K | 207.63K | 205.49K |
| EPS (Basic) | -9.71 | -13.06 | -11.32 | -7.49 | -28.97 | -25.42 | -66.62 | -68.52 | -132.9 | -173.87 | -234.57 |
| EPS (Diluted) | -9.71 | -13.06 | -11.32 | -7.49 | -28.97 | -25.42 | -66.62 | -68.52 | -132.9 | -173.87 | -234.57 |
| EBITDA | -25.41M | -24.77M | -17.52M | -12.02M | -19.97M | -20.14M | -50.56M | -54.69M | -38.87M | -29.23M | -35.3M |
| Depreciation & Amortization | 90K | 92K | 89K | 94K | 39K | 218K | 197K | 265K | 501K | 864K | 1.09M |